|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7120 USD | -3.20% |
|
-14.72% | -84.17% |
Company Valuation: FibroBiologics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| Market Cap 1 | 70.17 | 14.96 | 3.844 | - | - |
| Change | - | -78.68% | -74.3% | - | - |
| Enterprise Value (EV) | 70.17 | 14.96 | 3.844 | 3.844 | 3.844 |
| Change | - | -78.68% | -74.3% | 0% | 0% |
| P/E | -5.88x | -0.54x | -0.72x | -0.33x | -0.29x |
| PBR | - | - | - | - | - |
| PEG | 0.1x | -0x | 0x | -0x | -0x |
| Capitalization / Revenue | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0.19x | -0.16x | -0.13x |
| EV / FCF | -0x | - | -0.19x | -0.14x | -0.1x |
| FCF Yield | -17.2% | - | -521% | -705% | -956% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -6.8 | -8.4 | -0.99 | -2.177 | -2.423 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -13.74 | -16.65 | -20.42 | -24.01 | -29.83 |
| Net income 1 | -11.16 | -18.65 | -20.36 | -24.01 | -29.5 |
| Net Debt | - | - | - | - | - |
| Reference price 2 | 40.0000 | 4.4980 | 0.7120 | 0.7120 | 0.7120 |
| Nbr of stocks (in thousands) | 1,754 | 3,326 | 5,399 | - | - |
| Announcement Date | 3/31/25 | 2/24/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72x | - | - | - | 3.84M | |
| 33.56x | 8.36x | 25.84x | 0.05% | 57.28B | |
| 20.68x | 6.37x | 13.94x | 1.54% | 54.99B | |
| -41.86x | 13.29x | -39.17x | -.--% | 23.18B | |
| -17.88x | 4.15x | -7.26x | -.--% | 22.59B | |
| 25.74x | 5.04x | 13.35x | -.--% | 20.46B | |
| 24.54x | 4.77x | 15.5x | -.--% | 17.56B | |
| -523.64x | 37.41x | -1539.29x | -.--% | 15.67B | |
| 43.58x | 17.61x | 45.34x | 0.08% | 14.46B | |
| 17.42x | 5.04x | 11.77x | -.--% | 13.92B | |
| Average | -41.86x | 11.34x | -162.22x | 0.19% | 24.01B | |
| Weighted average by Cap. | -19.52x | 9.70x | -89.86x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- FBLG Stock
- Valuation FibroBiologics, Inc.
Select your edition
All financial news and data tailored to specific country editions
